观点光大证券

Tough justice for Everbright is best medicine for China

What if JPMorgan’s multibillion-dollar “London whale” trading losses had led regulators to ban Jamie Dimon, chief executive, from markets for life and forbidden the bank from ever investing again in credit derivatives?

Such a draconian scenario might sound far-fetched in the US or Europe. But this is exactly the scale of the punishment that has been meted out in China against Everbright Securities, after the brokerage committed a massive trading error two weeks ago and tried to conceal it.

The Everbright scandal has received scant attention outside China – which is perhaps understandable given the closed nature of the country’s markets: few foreign institutions or investors have been directly affected by it. Yet it is an extraordinary story that merits a closer look, because it exposes the ugly underbelly of China’s brokerage industry and shows that regulators are serious about whipping it into shape.

您已阅读20%(912字),剩余80%(3700字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归manbetx20客户端下载 所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×